MEMPHIS, Tenn., April 27, 2016 /PRNewswire-USNewswire/ -- Delivering on a Promise is a publication highlighting Le Bonheur Children's Hospital's newest programs, research breakthroughs and innovative ways of caring for children. The Spring 2016 edition features the story of scientists at Le Bonheur who are leading the first U.S. pediatric clinical trial of a new respiratory syncytial virus (RSV) antiviral in nearly 40 years, after demonstrating the new drug concept's success in fighting RSV in healthy adults.
Learn more by viewing the story, On Trial, published in the latest Delivering on a Promise at www.lebonheur.org/promise.
About Le Bonheur Children's Hospital
Le Bonheur Children's Hospital in Memphis, Tenn., treats more than 250,000 children each year through community programs, regional clinics and a 255 bed state-of-the-art hospital. Le Bonheur serves as a primary teaching affiliate for the University of Tennessee Health Science Center and trains more than 350 pediatricians and specialists each year. Nationally recognized, Le Bonheur is recognized by U.S. News & World Report as a Best Children's Hospital.
Media Contact: David Henson, David.Henson@lebonheur.org, 1-901-287-6030
SOURCE Le Bonheur Children's Hospital